Croda Pharma offers over eight decades of specialized expertise in pharmaceutical solutions. With a steadfast commitment to quality, precision, and sustainability, we are here to collaborate with industry leaders to advance pharmaceutical innovation.
Global Reach and Collaboration: Operating across Europe, North America, and Asia, Croda provides seamless global support to its partners. Our lipid technologies were instrumental in enabling the rapid development and rollout of mRNA-based COVID-19 vaccines, demonstrating our capacity to address critical challenges in healthcare.
Super Refined™ Excipients: Croda’s Super Refined™ excipients are engineered to deliver the highest levels of purity, reducing impurities that can impact drug stability and performance. These excipients ensure reliable and reproducible outcomes, supporting robust and effective formulations.
Innovative Adjuvant Systems: With over 80 years of experience, Croda has developed advanced adjuvant systems that amplify vaccine efficacy. These systems are tailored to meet stringent safety and performance requirements, enhancing immune responses across a range of vaccine platforms.
Specialized Lipid Technologies: Croda’s lipids are key components in the stabilization and delivery of nucleic acid therapies, including mRNA vaccines and gene editing technologies. Our lipids provide the reliability and functionality necessary to support groundbreaking treatments.